Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy
Agnes Bonifacius, Sabine Tischer‐Zimmermann, Maria Michela Santamorena, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 10

Showing 10 citing articles:

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Spyridoula Vasileiou, LaQuisa C. Hill, Manik Kuvalekar, et al.
Haematologica (2022) Vol. 108, Iss. 7, pp. 1840-1850
Open Access | Times Cited: 20
Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients
Michael Koldehoff, Britta Eiz‐Vesper, Britta Maecker‐Kolhoff, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 845-845
Open Access | Times Cited: 6
SARS-CoV-2 Immunity in Hematopoietic Stem Cell Transplant and Cell Therapy Recipients: What Do We Know, and What Remains to Be Determined?
José Luís Piñana, Manuel Guerreiro, Carlos Solano
Hemato (2023) Vol. 4, Iss. 2, pp. 170-183
Open Access | Times Cited: 3
Immune-Cell-Based Therapy for COVID-19: Current Status
Yiyuan Wang, Qinghe Liang, Fengsheng Chen, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2148-2148
Open Access | Times Cited: 2
A phase I/II study of adoptive SARS-CoV-2-specific T cells in immunocompromised hosts with or at risk of severe COVID-19 infection
Michaela Su-Fern Seng, King Pan Ng, Teck Guan Soh, et al.
Cytotherapy (2024) Vol. 26, Iss. 10, pp. 1170-1178
Open Access
Virus-Specific T Cells From Cryopreserved Blood During an Emergent Virus Outbreak for a Potential Off-the-Shelf Therapy
Rut Mora‐Buch, Maria Tomás‐Marín, Emma Enrich, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 9, pp. 572.e1-572.e13
Open Access | Times Cited: 1
Assessment of cell-mediated immune responses to SARS-CoV-2 in Syrian hamsters
Daria Mezhenskaya, Irina Isakova–Sivak, Larisa Rudenko
Medical academic journal (2022) Vol. 2, Iss. 2, pp. 215-220
Closed Access | Times Cited: 1
Antigen-Specific T Cells and SARS-CoV-2 Infection: Current Approaches and Future Possibilities
Zuzana Nová, Tomáš Zemánek, Norbert Botek
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15122-15122
Open Access | Times Cited: 1
COVID-19 and Hematopoietic Stem Cell Transplantation
Chiara Oltolini, Raffaella Greco, Maria Teresa Lupo Stanghellini
Springer eBooks (2023), pp. 177-192
Closed Access
Zytotoxische T-Zellprodukte – eine mögliche Option bei schwerem COVID-Verlauf

Transfusionsmedizin (2022) Vol. 12, Iss. 03, pp. 142-143
Closed Access
Page 1

Scroll to top